Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Company Overview - Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company focused on complement science to develop therapies for challenging diseases [2] - The company has introduced the first new class of complement medicine in 15 years, with two C3-targeting medicines approved for four serious diseases [2] - Notable breakthroughs include the first therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients aged 12 and older with C3G or primary IC-MPGN, both severe and rare kidney diseases [2] Upcoming Events - Apellis Pharmaceuticals will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at 11:15 a.m. PT [1] - A live conference webcast will be available on the company's website, with a replay accessible for approximately 90 days post-event [1]